Teprotumumab as Monotherapy for Dysthyroid Optic Neuropathy: A Multicenter Study

Authors

Giannis Moustafa
Irina Belinsky
Cat Burkat
Stella Chung
Brent Hayek
Alon Kahana, Beaumont Health
Amina Malik
John Nguyen
Sathyadeepak Ramesh
Sarah Turner, Beaumont Health
Alison Watson
Roman Shinder

Document Type

Conference Proceeding

Publication Date

11-2-2023

First Page

57

Comments

American Society of Ophthalmic Plastic and Reconstructive Surgery 54th Annual Fall Scientific Symposium, November 2-3, 2023, San Francisco, CA

Last Page

57

Recommended Citation

Moustafa G, Belinsky I, Burkat C, Chung S, Hayek B, Kahana A, et al. [Turner S]. Teprotumumab as monotherapy for dysthyroid optic neuropathy: a multicenter study. Presented at: American Society of Ophthalmic Plastic and Reconstructive Surgery 54th Annual Fall Scientific Symposium; 2023 Nov 2; San Francisco, CA. Available from: https://asoprs.memberclicks.net/assets/Meetings/fall/ASOPRS_2023_Fall_Program.pdf